Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Profit After Tax (2016 - 2025)

Historic Profit After Tax for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$9.0 million.

  • iBio's Profit After Tax fell 10607.24% to -$9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$24.7 million, marking a year-over-year decrease of 2815.11%. This contributed to the annual value of -$18.4 million for FY2025, which is 2621.75% up from last year.
  • As of Q4 2025, iBio's Profit After Tax stood at -$9.0 million, which was down 10607.24% from -$5.7 million recorded in Q3 2025.
  • In the past 5 years, iBio's Profit After Tax ranged from a high of $114000.0 in Q2 2021 and a low of -$40.6 million during Q2 2023
  • Its 5-year average for Profit After Tax is -$8.5 million, with a median of -$6.5 million in 2022.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 10322.03% in 2021, then plummeted by 921140.35% in 2022.
  • iBio's Profit After Tax (Quarter) stood at -$7.2 million in 2021, then tumbled by 46.89% to -$10.6 million in 2022, then rose by 22.27% to -$8.2 million in 2023, then soared by 46.85% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
  • Its Profit After Tax was -$9.0 million in Q4 2025, compared to -$5.7 million in Q3 2025 and -$5.2 million in Q2 2025.